Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on January 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

KamTek, Inc. (KTI) Freezer Services

Closed
HT942726CC0129Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

493120 - Refrigerated Warehousing and Storage

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency (dha)
Contacts2 people available
OfficeN/A

Full Description

Show more

This notice announces the intent by the DHA Contracting Activity (DHACA) Fort Detrick, Maryland, 21702, to award a sole source Firm-Fixed-Price (FFP) Contract to KamTek, Inc. (KTI), under the statutory authority FAR 6.103-1(b), One responsible source. The contract is to provide 24-hour monitoring and storage of two (2) IHD-owned and one (1) rented upright, -80⁰C (ultralow) freezers.


The freezers requiring storage and monitoring contain plasma, saliva, and serum samples related to investigations of rare adverse events following immunizations conducted over the past 20 years. These samples are irreplaceable and critically dependent on maintaining a constant temperature within a narrow range. KamTek, Inc. (KTI) is the only vendor capable of meeting all requirements to ensure the integrity of these samples. Their facility provides comprehensive, 24/7 monitoring through the Rees Scientific Monitoring System, which immediately alerts KTI staff to any temperature deviations. In the event of a freezer malfunction, KTI staff swiftly transfers the contents to backup freezers until repairs or replacements are completed. Additionally, KTI employs a robust security system that monitors environmental conditions, such as temperature and water levels, and provides standby generator power during outages. KTI is uniquely positioned to meet the operational needs of IHD Clinical Investigations staff, who require efficient and minimal-notice access to the freezers. Unlike other vendors, KTI grants access within 24 hours at no additional cost and provides bench space for inventory management, quality control, and sample verification. Competing vendors impose advance notice requirements and charge fees for program management and repository escort services, which would result in an estimated $18,000 in annual costs. These additional costs are not feasible within IHD’s budget. KTI’s facility also meets stringent security requirements, including locked entry, visitor authorization protocols, and sign-in logs. Freezers remain locked until authorized users arrive. No other vendor offers this level of security and accessibility. Relocating the freezers to another facility would incur significant costs, including white-glove specialized transport to maintain temperature control, potential damage to the aging freezers, and replacement costs estimated at $30,000. Furthermore, the samples stored in these freezers must be kept frozen within a specific temperature range to maintain integrity. The samples represent over 20 years of work and are irreplaceable, making relocation a high-risk and impractical option. KTI is the only vendor capable of meeting all requirements outlined in the Performance Work Statement (PWS) within a single facility. Their proximity to Walter Reed National Military Medical Center allows IHD staff to conduct quarterly site visits efficiently, avoiding additional travel costs and time. KTI also provides an emergency rental freezer and is certified to perform preventative maintenance and calibration on both IHD-owned and rental freezers. Their expertise in monitoring and maintaining these specific freezers ensures seamless operations, whereas a new vendor would require extensive training on IHD’s equipment, further delaying operations and increasing costs. Transporting these freezers to another facility would impose substantial costs on the government, including special transport fees, set-up fees with recalibration costs at the new location, and potential replacement costs due to damage of equipment in transport. These substantial costs, along with potential repository access fees, are not within IHD’s budget. Without KTI’s services, IHD would face significant challenges in meeting critical Department of Defense regulations, including DODI 6205.02, DoDD 6200.04, and DoDI 6490.03, among others. This could result in the loss of thousands of repository specimens essential for rapid and cost-effective investigations of rare adverse events following immunizations. KTI is the only vendor capable of meeting all operational, security, and regulatory requirements while ensuring the integrity of these irreplaceable samples. Their unique capabilities, proximity, and cost-effective services make them the sole viable option for this contract.


Period of Performance:


            Base Period: 01 March 2026 through 28 February 2027


            Option Period 01: 01 March 2027 through 29 February 2028


            Option Period 02: 01 March 2028 through 28 February 2029


            Option Period 03: 01 March 2029 through 28 February 2030


            Option Period 04: 01 March 2030 through 28 February 2031



The North American Industry Classification System (NAICS) for this requirement is 493120 and the size standard is $32 million. 


This announcement fulfills the synopsis requirements under FAR 5.102(a)(6) and 5.203(a). DHACA intends to award a contract no sooner than 15 days after publishing this synopsis. This Special Request for Information is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the expiration date listed in this notice, which reflects at least fifteen (15) days after the publication of this notice, the award will be issued as sole source. All questions and responses concerning this notice shall be emailed to Mr. Christopher L. Cook at christopher.l.cook68.civ@health.mil. 



More opportunities from Department Of Defense → Defense Health Agency (dha)

Same awarding agency

NAICS: 325412
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9404
The Defense Health Agency, acting for the Department of War, is soliciting quotes under solicitation HT9402-26-Q-9404 to establish Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program agreements. This procurement is mandated by 10 U.S.C. 1074g to create an integrated pharmacy benefits program for the Military Health System, covering Military Treatment Facilities, the TRICARE Mail Order Pharmacy, and the Basic Core Formulary. The Pharmacy and Therapeutics Committee will evaluate pharmaceutical agents based on relative clinical effectiveness and cost effectiveness to determine their placement on the Uniform Formulary. Specifically, the November 2026 review includes twelve newly approved drugs across various classes, including oncological agents, antifungals, and insulins. Interested manufacturers must submit quotes by October 26, 2026, and provide detailed clinical data regarding the advantages and therapeutic placement of their drugs. Key requirements include maintaining active SAM.gov registration, ensuring Trade Agreements Act compliance via FAR 52.225-6, and agreeing to utilize the Department of War Prime Vendor Program for distribution. The agreement also requires opening limited distribution channels to Accred for mail order services. Award decisions are based on the combined evaluation of clinical and cost effectiveness, with the TRICARE retail network utilization accrual beginning upon the Contracting Officer's signature. The contract allows for termination by either party with 120 days written notice.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 6 days
View Details
NAICS: 541715
Federal
DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Solicitation # HT003826SC005
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 561910
Federal
DHA - Offsite Sterile Processing Support Services
Solicitation # HT9427-27-RFI-0001
The Defense Health Agency (DHA) is issuing a Request for Information (RFI) to identify qualified contractors capable of providing offsite Sterile Processing (SP) support for various Military Treatment Facilities (MTFs) across eight DHA networks. This initiative is part of a Business Case Analysis to improve service resilience and workload stability, ensuring that surgical capabilities are not halted by onsite equipment failures. The scope of work involves the transportation of surgical instruments between MTFs and contractor-owned offsite facilities, where the contractor will provide the necessary personnel, equipment, and facilities to perform decontamination, assembly, sterilization, inventory verification, and quality control. The equipment to be processed includes specialized items such as minimally invasive surgical cases, Da Vinci accessories, and power equipment, with an estimated volume of approximately 2,000 trays monthly per participating MTF. This RFI is strictly for market research and planning purposes and does not constitute a formal solicitation or an obligation to award a contract. The DHA is seeking capability statements from healthcare companies and hospitals that detail their experience with similar projects over the last five years and their proposed implementation strategy. Responses must be submitted in PDF format to the designated Contract Specialist by 11:00 AM EDT on October 30, 2026, and are limited to 10 pages using a 12-point font. The government has not yet determined if a small business set-aside is appropriate and will use the information gathered from these responses to make that decision.
Packaging and Labeling Services

POSTED

21 days ago

DEADLINE

in 10 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS